House Bill Aims To Limit Oxycodone Prescriptions

Law360, New York (March 22, 2013, 6:17 PM EDT) -- House legislation introduced Thursday would order the U.S. Food and Drug Administration to modify approval of oxycodone products so that they’d only be cleared for patients with severe pain, the latest bit of bipartisan pressure on regulators to rein in highly addictive pain relievers.

The Stop Oxy Abuse Act, which has been introduced in at least two previous congressional sessions but died in committee, would bar approval of extended-release oxycodone products for moderate pain, as is currently allowed.

Previously advocated by former Rep. Mary Bono Mack,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.